Latest filing published 28 May 2018 for Valeant Pharmaceuticals International, Inc.. Read the official filing
All filings by David Robert Hale on record concern Valeant Pharmaceuticals International, Inc. Over a trading history stretching from 19 August 2015 to 23 May 2018, the count stands at 4 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 28 May 2018 with a transaction in Valeant Pharmaceuticals International, Inc. Typically, a trade is published a median of 4 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations